India's Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher. The company's consolidated ...

led by continued demand for its bundle test offerings, sending its shares 3% higher. The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31 ...